Moxetumomab pasudotox in heavily pretreated patients with relapsed/refractory hairy cell leukemia: Results of a pivotal international studyP. le Coutre, M. Rummel,R. J. Kreitman,C. Dearden,P. L. Zinzani,J. Delgado,T. Robak,B. T. Gjertsen,X. Troussard,G. Saglio,G. Roboz,L. Karlin,D. Gladstone,K. Balic,N. Standifer,P. He,S. Marshall,W. Wilson,I Pastan,N. S. Yao,D. Dietrich,F. GilesJOURNAL OF CLINICAL ONCOLOGY（2018）引用 3|浏览14暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
